Literature DB >> 26503265

Cortical Layer Inversion and Deregulation of Reelin Signaling in the Absence of SOCS6 and SOCS7.

Isobel D Lawrenson1, Danielle L Krebs1,2, Edmond M Linossi1,3, Jian-Guo Zhang1,3, Tamara J McLennan1, Caitlin Collin1, Helen M McRae1,3, Tatiana B Kolesnik1, Katrina Koh1,3, Joanne M Britto4, Andrew J Kueh1,3, Bilal N Sheikh1,3, Farrah El-Saafin1,3, Nicos A Nicola1,3, Seong-Seng Tan4, Jeffrey J Babon1,3, Sandra E Nicholson1,3, Warren S Alexander1,3, Tim Thomas1,3, Anne K Voss1,3.   

Abstract

Mutations of the reelin gene cause severe defects in cerebral cortex development and profound intellectual impairment. While many aspects of the reelin signaling pathway have been identified, the molecular and ultimate cellular consequences of reelin signaling remain unknown. Specifically, it is unclear if termination of reelin signaling is as important for normal cortical neuron migration as activation of reelin signaling. Using mice that are single or double deficient, we discovered that combined loss of the suppressors of cytokine signaling, SOCS6 and SOCS7, recapitulated the cortical layer inversion seen in mice lacking reelin and led to a dramatic increase in the reelin signaling molecule disabled (DAB1) in the cortex. The SRC homology domains of SOCS6 and SOCS7 bound DAB1 ex vivo. Mutation of DAB1 greatly diminished binding and protected from degradation by SOCS6. Phosphorylated DAB1 was elevated in cortical neurons in the absence of SOCS6 and SOCS7. Thus, constitutive activation of reelin signaling was observed to be equally detrimental as lack of activation. We hypothesize that, by terminating reelin signaling, SOCS6 and SOCS7 may allow new cycles of reelin signaling to occur and that these may be essential for cortical neuron migration.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 26503265     DOI: 10.1093/cercor/bhv253

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  7 in total

1.  RBX2 maintains final retinal cell position in a DAB1-dependent and -independent fashion.

Authors:  Corinne L Fairchild; Keiko Hino; Jisoo S Han; Adam M Miltner; Gabriel Peinado Allina; Caileigh E Brown; Marie E Burns; Anna La Torre; Sergi Simó
Journal:  Development       Date:  2018-02-02       Impact factor: 6.868

2.  Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.

Authors:  Shengshu Li; Xiaoxin Lu; Dongyang Zheng; Weizong Chen; Yuzhu Li; Fang Li
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-30       Impact factor: 4.322

3.  Mllt11 Regulates Migration and Neurite Outgrowth of Cortical Projection Neurons during Development.

Authors:  Danielle Stanton-Turcotte; Karolynn Hsu; Samantha A Moore; Makiko Yamada; James P Fawcett; Angelo Iulianella
Journal:  J Neurosci       Date:  2022-04-04       Impact factor: 6.709

Review 4.  Reelin Functions, Mechanisms of Action and Signaling Pathways During Brain Development and Maturation.

Authors:  Yves Jossin
Journal:  Biomolecules       Date:  2020-06-26

5.  Circular RNA circ_103820 suppresses lung cancer tumorigenesis by sponging miR-200b-3p to release LATS2 and SOCS6.

Authors:  Yongbin Chi; Wenlong Zheng; Guangyu Bao; Lifeng Wu; Xiaoxue He; Ruyi Gan; Yan Shen; Xudong Yin; Mingming Jin
Journal:  Cell Death Dis       Date:  2021-02-15       Impact factor: 8.469

Review 6.  Canonical and Non-canonical Reelin Signaling.

Authors:  Hans H Bock; Petra May
Journal:  Front Cell Neurosci       Date:  2016-06-30       Impact factor: 5.505

7.  Importance and usage of chromosomal microarray analysis in diagnosing intellectual disability, global developmental delay, and autism; and discovering new loci for these disorders.

Authors:  Ahmet Cevdet Ceylan; Senol Citli; Haktan Bagis Erdem; Ibrahim Sahin; Elif Acar Arslan; Murat Erdogan
Journal:  Mol Cytogenet       Date:  2018-09-24       Impact factor: 2.009

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.